Trial · NCT07904468
Daily Cognitive Failures and Medication Adherence in Fibromyalgia
NCT07904468, Not yet recruiting, Mardin Artuklu University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Daily Cognitive Failures and Medication Adherence in Fibromyalgia. Trials, record NCT07904468. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07904468
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Daily Cognitive Failures and Medication Adherence in Fibromyalgia
- NCT number
- NCT07904468
- Status
- Not yet recruiting
- Enrollment
- 70 participants, estimated
- Lead sponsor
- Mardin Artuklu University
- Conditions
- Fibromyalgia
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Medication Adherence Assessed by MARS-5 in Relation to Pain Severity | Baseline | Medication adherence will be measured using the five-item Medication Adherence Report Scale (MARS-5). Total scores range from 5 to 25, with higher scores indicating better medication adherence. The association between MARS-5 total scores and pain severity, assessed using the Numeric Rating Scale (NRS; 0-10), will be examined as an exploratory analysis. MARS-5 will be the outcome variable, and pain severity will be the explanatory variable. |
| Secondary | Everyday Cognitive Failures Assessed by the Cognitive Failures Questionnaire (CFQ) | Baseline | Everyday cognitive failures will be assessed using the 25-item Cognitive Failures Questionnaire (CFQ). Each item is scored from 0 to 3, yielding a total score ranging from 0 to 75. Higher scores indicate more frequent everyday cognitive failures, whereas lower scores indicate fewer cognitive failures. |
| Secondary | Anxiety Symptoms Assessed by the Hospital Anxiety and Depression Scale (HADS-A) | Baseline | Anxiety symptoms will be assessed using the seven-item anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). Each item is scored from 0 to 3, yielding a total score ranging from 0 to 21. Higher scores indicate more severe anxiety symptoms, whereas lower scores indicate fewer anxiety symptoms. |
| Other | Pain Severity Assessed by the Numeric Rating Scale (NRS) | Baseline | Average fibromyalgia pain severity during the preceding week will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity, whereas lower scores indicate less pain. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07904468
GET https://conductscience.org/api/trials/v1/NCT07904468/registered